Crown Melbourne Fined $2 Million by Victorian Gambling Regulator

Crown Melbourne Fined $2 Million by Victorian Gambling Regulator

Crown Melbourne has been fined $2 million by the Victorian Gambling and Casino Control Commission (VGCCC) for allowing 242 self-excluded individuals to gamble over an 8-month period.

Narayana Hrudayalaya Share Price in Focus after ICICI Direct Ratings Upgrade

Narayana Hrudayalaya Share Price in Focus after ICICI Direct Ratings Upgrade

ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro

Upstart Holdings (UPST) Stock Price Jumps 15% after Upgrade from Wedbush Securities

Upstart Holdings (UPST) Stock Price Jumps 15% after Upgrade from Wedbush Securities

Shares of Upstart (NASDAQ: UPST), an AI-driven lending platform, soared by 17.5% following upgrade from Wedbush Securities, citing improved credit metrics and a favorable macroeconomic environment.

Longboard Pharmaceuticals Stock Price Jumps as Lundbeck A/S Acquires Controlling Stake for $60 per Share

Longboard Pharmaceuticals Stock Price Jumps as Lundbeck A/S Acquires Controlling Stake for $60 per Share

H. Lundbeck A/S, a prominent Danish pharmaceutical company, has announced its largest-ever acquisition, agreeing to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion.

Palantir Technologies (PLTR) Stock Price Closes Flat after Touching 52-week High; Results on November 4

Palantir Technologies (PLTR) Stock Price Closes Flat after Touching 52-week High; Results on November 4

Palantir Technologies stock price closed almost flat on Monday. Palantir opened the trading session at $43.72 and touched 52-week high of $44.39 before closing the session almost flat at $43.40.

IPCA Laboratories Share Price in Focus as Motilal Oswal Suggests BUY Call with 18% Upside Potential

IPCA Laboratories Share Price in Focus as Motilal Oswal Suggests BUY Call with 18% Upside Potential

Motilal Oswal's research report has upgraded IPCA Laboratories to a "BUY" recommendation with a target price of Rs 1,950, an upside of 18% from its current market price of Rs 1,659.

Pages

News in Focus

Crown Melbourne Fined $2 Million by Victorian Gambling Regulator

Crown Melbourne has been fined $2 million by the Victorian Gambling and Casino Control Commission (VGCCC) for allowing 242 self-excluded individuals to gamble over an 8-month period.

Narayana Hrudayalaya Share Price in Focus after ICICI Direct Ratings Upgrade

ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro

Upstart Holdings (UPST) Stock Price Jumps 15% after Upgrade from Wedbush Securities

Shares of Upstart (NASDAQ: UPST), an AI-driven lending platform, soared by 17.5% following upgrade from Wedbush Securities, citing improved credit metrics and a favorable macroeconomic environment.

Longboard Pharmaceuticals Stock Price Jumps as Lundbeck A/S Acquires Controlling Stake for $60 per Share

H. Lundbeck A/S, a prominent Danish pharmaceutical company, has announced its largest-ever acquisition, agreeing to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion.

Palantir Technologies (PLTR) Stock Price Closes Flat after Touching 52-week High; Results on November 4

Palantir Technologies stock price closed almost flat on Monday. Palantir opened the trading session at $43.72 and touched 52-week high of $44.39 before closing the session almost flat at $43.40.

IPCA Laboratories Share Price in Focus as Motilal Oswal Suggests BUY Call with 18% Upside Potential

Motilal Oswal's research report has upgraded IPCA Laboratories to a "BUY" recommendation with a target price of Rs 1,950, an upside of 18% from its current market price of Rs 1,659.